Denali Therapeutics
Latest round
- Series B
Last raised
- Aug 2016
Total raised
- $349M
Investors
- 5
About Denali Therapeutics
Denali Therapeutics Inc.Founded in 2015, Denali Therapeutics Inc. is based in San Francisco, US, and specializes in developing treatments for neurodegenerative diseases.00 mn, primarily through a recent Private Placement/Follow on in October 2022.Denali Therapeutics focuses on the discovery and development of innovative therapeutics targeting neurodegenerative and lysosomal storage diseases. Their core offerings include advanced drug candidates designed to address critical pathways involved in diseases such as Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS), and Hunter Syndrome. Denali's flagship product, DNL310, employs a novel transport vehicle technology aimed at improving the delivery of therapeutics across the blood-brain barrier, a significant challenge in treating neurological disorders. The end-users of these therapeutics are primarily patients suffering from these debilitating conditions, and the company actively partners with healthcare providers and research institutions to facilitate treatment access.55 mn. The company generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research institutions that facilitate the development and commercialization of its therapeutics. The company is also looking to expand its reach into additional markets, focusing on North America, Europe, and targeted regions in Asia by 2024. Denali’s strategies include developing innovative solutions to improve patient outcomes and addressing the significant unmet clinical needs in neurodegenerative diseases.
Who invested in Denali Therapeutics
5 investors across 3 rounds
See all investors in Denali Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Denali Therapeutics
Who invested in Denali Therapeutics?
Denali Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Denali Therapeutics raised?
Denali Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Denali Therapeutics last raise money?
Denali Therapeutics's most recent round on record is a Series B, in Aug 2016.
What does Denali Therapeutics do?
Denali Therapeutics is a biotechnology company.
Where is Denali Therapeutics headquartered?
Denali Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Denali Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Denali Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Denali Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.